An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to assess the anti-exenatide-antibody response to
exenatide re-exposure as measured by anti-exenatide antibodies and incidence of
treatment-emergent allergy and hypersensitivity reactions following a period of treatment
interruption, in patients previously exposed to exenatide.